Matthew Eves, MD
Gastroenterology · Mobile, ALNPI 1255362661
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,865 of the $45,627 with a category attached, or 72.0%. Boston Scientific accounts for 79.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $25,115 and has fallen 98.9% since, to $272 in 2025. Among gastroenterology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 138 payments — averaging $330.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$36K
- Wilson Cook Medical Incorporated$5K
- Olympus Corporation Of The Americas$3K
- Cook Medical LLC$490
- Braintree Laboratories, Inc.$273
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$188
- plus $1K from 15 others
Across 1 payment — averaging $357.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$358
What the payments were for
- Consulting fees$3,7508%
- Speaking & faculty fees$32,86572%
- Travel & lodging$5,51512%
- Food & beverage$3,2247%
- Education$240%
- Gifts$2501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 52 | $36,103 |
| Wilson Cook Medical Incorporated | 1 | $4,650 |
| Olympus Corporation Of The Americas | 21 | $2,884 |
| Cook Medical LLC | 10 | $490 |
| Braintree Laboratories, Inc. | 9 | $273 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $188 |
| AbbVie(2 entities) | 11 | $174 |
| Apollo Endosurgery US Inc | 2 | $118 |
| Axonics, Inc. | 2 | $114 |
| Covidien LP | 2 | $106 |
| Lumendi LLC | 2 | $100 |
| Endogastric Solutions, Inc | 1 | $99 |
| Fujifilm Healthcare Americas Corporation | 1 | $85 |
| Pfizer | 2 | $73 |
| Olympus America Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Gilead | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Bristol Myers Squibb | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$6,478
- ECHOTIP INSIGHT$4,778
- HABIB ENDOHPB$3,187
- Single Use Electrosurgical Knife KD-655$1,810
- Single Use Electrosurgical Hemostatic Forceps$1,458
- SPYGLASS$951
- GENERAL HEMOSTASIS$756
- Single Use Aspiration Needle NA-U200H$500
- GENERAL - THERAPIES$486
- SINGLE USE SUCTION VALVE (Sterile)$262
- GENERAL ENDOCHOICE$101
How this compares
$45,627 in reported general payments places this provider in the 95th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 168 | $10,858 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 49 | $7,662 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 37 | $928 |
| Pantoprazole Sodium | 81 | $808 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 24 | $801 |
| Sucralfate | 17 | $582 |
| Ondansetron Hcl | 11 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $273 | $7,66249 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 225 gastroenterology providers in Alabama.
Other gastroenterology in Mobile
- Jack DipalmaMobile$903K
- Phillip HendersonMobile$462K
- William SonnierMobile$178K
- Jorge HerreraMobile$167K
- Michael SandersMobile$25K
- Susan FleetMobile$15K
- Jonathan SiegelMobile$15K
- Panayiotis GrevenitisMobile$11K
- Cody BarnettMobile$10K
- Mason AdamsMobile$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.